AIP
BOLD

Ameritas Investment Partners’s Audentes Therapeutics, Inc BOLD Stock Holding History

Ameritas Investment Partners’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-3,930
Closed -$235K – 3071
2019
Q4 		$235K Buy
3,930
+184
+5% +$6.91K 0.01% 998
2019
Q3 		$105K Hold
3,746
– – ﹤0.01% 1440
2019
Q2 		$142K Buy
3,746
+665
+22% +$25.5K 0.01% 1275
2019
Q1 		$120K Buy
3,081
+585
+23% +$16.8K 0.01% 1364
2018
Q4 		$53K Hold
2,496
– – ﹤0.01% 1791
2018
Q3 		$99K Hold
2,496
– – ﹤0.01% 1581
2018
Q2 		$95K Buy
2,496
+802
+47% +$29.7K ﹤0.01% 1587
2018
Q1 		$51K Buy
1,694
+355
+27% +$12K ﹤0.01% 1917
2017
Q4 		$42K Hold
1,339
– – ﹤0.01% 2023
2017
Q3 		$28K Hold
1,339
– – ﹤0.01% 2244
2017
Q2 		$26K Buy
1,339
+931
+228% +$14.9K ﹤0.01% 2321
2017
Q1 		$7K Buy
+408
New +$6.6K ﹤0.01% 2798

Ameritas Investment Partners's BOLD Position: Q1 2020 in Review

Ameritas Investment Partners sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 3,930 shares — an estimated $235K sold.

Ameritas Investment Partners first reported a position in BOLD in Q1 2017 and held it in 12 quarters. The position peaked at $235K in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

  • Ameritas Investment Partners reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
  • Ameritas Investment Partners sold 3,930 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $235K.
  • Ameritas Investment Partners first reported a position in Audentes Therapeutics, Inc in Q1 2017 and held it in 12 quarters.
  • Ameritas Investment Partners's Audentes Therapeutics, Inc position peaked at $235K in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Ameritas Investment Partners's 13F filing for Q1 2020, filed 13 May 2020.